The clinical course of patients with acute myocardial infarction who are unsuitable for thrombolytic therapy because of the presenting electrocardiogram

Coronary Artery Disease

Volumn 9, Issue 11, 1998, Pages 747-752

  Wong, Peter S C ^a   El Gaylani, Nadia ^b   Griffith, Kathryn ^c   Dixon, Gaynor ^a   Robinson, Derek R ^d   Norris, Robin M ^a  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c YORK HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Acute myocardial infarction; ST depression; Thrombolysis ineligible AMI

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DISEASE COURSE; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; GENERAL HOSPITAL; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; Q WAVE; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; T WAVE; UNITED KINGDOM;

EID: 0032409089     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199809110-00007     Document Type: Article

References (28)

1. Gruppo Italiano per lo Studio della Streptochinasi nell Infarcto miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; i:397-401.
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988; ii:349-360.
3. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1,000 patients. Lancet 1994; 343:311-322.
4. Lee HS, Cross SJ, Rawles JM, Jennings KP. Patients with suspected myocardial infarction who present with ST depression. Lancet 1993; 342:1204-1207.
5. Langer A, Goodman SG, Topol EJ, Charlesworth A, Skene AM, Wilcox RG, Armstrong PW, for the LATE study investigators. Late Assessment of Thrombolytic Efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. J Am Coll Cardiol 1996; 27:1327-1332.
6. Norris RM, on behalf of the United Kingdom Heart Attack Study Collaborative Group. Fatality outside hospital from acute coronary events in three British Health Districts 1994-95. BMJ 1998; 316: 1065-1070.
7. The UK Heart Attack Study Collaborative Group. Effect of time from onset to coming under care on fatality of patients with acute myocardial infarction. Heart 1998; 80:114-120.
8. The UK Heart Attack Study Collaborative Group. The declining mortality from coronary heart disease: a clinico-pathological perspective. Heart 1998; 80:121-126.
9. Huey BL, Beller GA, Kaiser DL, Gibson RS. A comprehensive analysis of myocardial infarction due to left circumflex artery occlusion: comparison with infarction due to right coronary artery and left anterior descending artery occlusion. J Am Coll Cardiol 1988; 12:1156-1165.
10. El Gaylani N, Weston CF, Griffith K, Wong PSC, Norris RM, Penny WJ. Acute myocardial infarction: are there missed opportunities for reperfusion? Coronary Artery Dis 1998; 9:753-758.
11. Holland RP, Brooks H. Spatial and nonspatial influences on the TQ-ST segment deflection of ischaemia, theoretical and experimental analysis in the pig. J Clin Invest 1977; 60:197-214.
12. Lee HS, Brooks N, Jennings K. Patients with suspected myocardial infarction presenting with ST depression. Heart 1997; 77:493-494.
13. Boden WE, Kleiger RE, Gibson RS, Schwartz DJ, Schechtman KB, Capone RJ, et al., and the Diltiazem Reinfarction Study Group. Electrocardiographic evolution of posterior acute myocardial infarction: importance of early precordial ST segment depression. Am J Cardiol 1987; 59:782-787.
14. Nicod P, Gilpin E, Dittrich H, Polikar R, Hjalmarson A, Blacky AR, et al. Short and long term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. Circulation 1989; 79:528-536.
15. Aguirre FV, Younis LT, Chaitman BR, Ross AM, McMahon RP, Kern MJ, et al. for the TIMI II Investigators. Early and 1-year clinical outcome of patients with evolving non-Q wave versus Q wave myocardial infarction after thrombolysis. Results from the TIMI II study. Circulation 1995; 91:2541-2548.
16. Ogawa H, Hiramuri K, Haze K, Saito M, Sumiyoshi T, Fukami K, et al. Classification of non-Q wave myocardial infarction according to electrocardiographic findings. Br Heart J 1985; 54:473-478.
17. Boden WE, Gibson RS, Schechtman KB, Kleiger RE, Schwartz DJ, Capone RJ. et al. ST segment shifts are poor predictors of subsequent Q wave evolution in acute myocardial infarction. A natural history study of early non-Q wave infarction. Circulation 1989; 79:537-548.
18. Roberts MJD, McNeill AJ, Dalzell GWN, Wilson CM, Webb SW, Khan MM, et al. Double-blind randomised trial of alteplase versus placebo in patients with chest pain at rest. Eur Heart J 1993; 14:1536-1542.
19. White HD, French JK, Norris RM, Williams BF, Hart HH, Cross DB. Effects of streptokinase in patients presenting within 6 hours of prolonged chest pain with ST segment depression. Br Heart J 1995; 73:500-505.
20. Mulcahy R, AI Awadhi AH, de Buitleor M, Tobin G, Johnson H, Contoy R. Natural history of prognosis of unstable angina. Am Heart J 1985; 109:753-758.
21. Rutherford JD, Braunwald E, Cohn PF. Chapter 39 In: Braunwald E (editor) Heart Disease. Philadelphia: Saunders Co.; 1998. p. 1359.
22. Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, et al. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med 1992; 326:287-291.
23. Ambrose JA, Winters SL, Stern A, Eng A, Teichholz LE, Gorlin R, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985; 5:609-616.
24. Braunwald E, Cannon CP. Non-Q wave and ST segment depression myocardial infarction: is there a role for thrombolytic therapy? J Am Coll Cardiol 1996; 27:1333-1334.
25. Oler A. Whooley MA, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. JAMA 1996; 276:811-815.
26. Cohen M, Demers C, Gurfinkel EP, Turpie AGG, Fromell GJ, Goodman S, et al., for the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events Study Group. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997; 337:447-452.
27. Fragmin during Instability in Coronary artery disease (FRISC) Study Group. Low molecular weight heparin during instability in coronary artery disease. Lancet 1996; 347:561-568.
28. Lee HS, Bray CL. Levy R, Ray S, Ward C, Bennett DH, et al. Coronary angiography, cardiac function and early intervention in patients with suspected infarcts and ST depression [abstract]. Heart 1997; 77 (suppl 1):49.